Atlas Trials

Mesenchymal Stromal/Stem Cells-Derived Exosomes (MSC-Exos) Therapy for Type 2 Diabetes Mellitus Patients

Clinical trial NCT07144241 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07144241
Sponsor
Indonesia University
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2025-09-01
Primary completion
2025-12-31
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.